| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |